Gustavo Maegawa, M.D., PH.D.
NPI 1366671380 · Clinical Biochemical Genetics Physician · New York, NY
Enrolled with Medicare as Practitioner - Pediatric Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Gustavo Maegawa, M.D., PH.D. is a Clinical Biochemical Genetics Physician provider in New York, NY (NPI 1366671380).
Provider details
- NPI number
- 1366671380
- Entity type
- Individual
- Primary specialty
- Clinical Biochemical Genetics PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D., PH.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- D69890 (MD)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
- Medical Biochemical Genetics207SG0207X
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
17 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024.
| Drug | Part D claims (2024) |
|---|---|
| Agalsidase Betabrand: Fabrazyme | 20 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$4,981 across 6 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-07-12
- Last updated
- 2024-07-12
- Certified
- 2022-01-10
Frequently asked questions
- What is Gustavo Maegawa's NPI number?
- Gustavo Maegawa's National Provider Identifier (NPI) is 1366671380, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Gustavo Maegawa's specialty?
- Gustavo Maegawa is listed in the NPPES registry with a primary specialty of Clinical Biochemical Genetics Physician (Allopathic & Osteopathic Physicians).
- Where is Gustavo Maegawa located?
- Gustavo Maegawa's practice location on file with NPPES is 3959 Broadway # Ch-7n, New York, NY 10032-1559.
- What is Gustavo Maegawa's phone number?
- The practice phone number listed in the NPPES registry for Gustavo Maegawa is (212) 305-3627.
- Does Gustavo Maegawa accept Medicare?
- Gustavo Maegawa is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Gustavo Maegawa's NPI active?
- Yes — Gustavo Maegawa's NPI (1366671380) is active in the NPPES registry as of the last update on 2024-07-12.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.